ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q2 2014. The put-call ratio across all filers is 13.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $340,000,000 | -72.8% | 200,000 | -66.7% | 0.01% | -68.2% |
| Q2 2015 | $1,248,000,000 | +212.0% | 600,000 | +300.0% | 0.02% | +175.0% |
| Q2 2014 | $400,000,000 | -48.1% | 150,000 | -31.8% | 0.01% | -46.7% |
| Q1 2014 | $770,000,000 | -31.2% | 220,000 | -12.0% | 0.02% | -28.6% |
| Q4 2013 | $1,120,000,000 | +3.7% | 250,000 | -6.0% | 0.02% | -4.5% |
| Q3 2013 | $1,080,000,000 | -45.3% | 266,000 | -44.0% | 0.02% | -40.5% |
| Q2 2013 | $1,976,000,000 | – | 475,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |